Ligand validation:8INV

BUF: bufalin

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8INV_BUF_A_503	29%	57%	0.161	0.818	0.64	1	1	1	2	0	100%	1
4RES_BUF_A_2001	40%	42%	0.251	0.964	0.9	1.36	2	8	2	0	100%	1
7DDL_BUF_A_1121	35%	42%	0.249	0.94	0.91	1.33	2	7	2	0	100%	1
7D94_BUF_A_1121	30%	40%	0.288	0.953	0.94	1.37	2	9	1	0	100%	1
7W10_BUF_A_503	2%	51%	0.414	0.691	0.66	1.22	1	4	4	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.